. 2017 Oct 25;6(8):876–885. doi: 10.1530/EC-17-0293
This work is licensed under a Table 6.
Data extracted from all studies reporting a period of observation of small, non-functioning pNETs.
| Surveillance | Resected | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| All | Fit for surgery | (of % eligible) | Tissue diagnosis | Growth | Later metastases | Subsequent surgery | F/U | 5-year survival | |
| Cheema (3) | 22 | 2 | 2 (9%) | 0 | nr | 0 | 24 | ||
| Lee (19)a | 79b | 79b | 56 (41%) | 22 (18%) | 0 | 0 | 2b | 45 | 100% |
| Gaujoux (25)a | 46 | 42 | 21 (46%) | 6 | 0 | 8 | 34 | 100% | |
| Crippa (4) | 12 | 11 | 0 | 0 | 0 | 0 | 36 | ||
| Gratian (24)d | 368 | 65 | 27% | ||||||
| Kishi (5)c | 19 | 19 | 27 (59%) | 0 | 3 | 0 | 0 | 45 | |
| Jung (26)a | 85 | 85 | 60 (41%) | 16 (19%) | 15 | 0 | 12 | 31 | 100% |
| Sharpe (27)d | 71 | 21 | 34% | ||||||
| Massironi (6)c | 15 | 12 | Ga used | (1 MEN) | 0 | 0 | 36 | 100% | |
| Regenet (7) | 14 | 14 | 9 (65%) | nr | 2 | 0 | 34 | 100% | |
| Rosenberg (28)a | 15 | 10 | 0 | 3 | 0 | 28 | 100% | ||
| Sadot (29)a | 104 | 104 | 77 (43%) | 68 (65%) | 8b | 0 | 24 | 44 | 100% |
| Zhang (8)c | 38 | ?38 | 61 (62%) | 35 (92%) | ns | 9 | 3 | 57 | 53% |
| Totald | 449 | 416 (93%) | 281 (46%) | 173 (41%) | 38 (8.8%) | 14 (3.3%) | 49 (10.9%) | 38.4e | |
aIncluded in the Partelli systematic review (2); bData extracted from primary studies differing from Partelli review; cIncludes familial syndromes; dAnalyses of national databases; not included in totals due to unreliable coding; eMean of medians (months).
F/U, Follow-up; nr, not reported; ns, not significant.